Jasper Therapeutics, Inc. (JSPR)
1.715
0.00 (0.00%)
USD |
NASDAQ |
Dec 08, 16:00
1.65
-0.06
(-3.79%)
After-Hours: 20:00
Jasper Therapeutics EPS Diluted (Quarterly): -1.126 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cytokinetics, Inc. | -2.552 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.74M |
| Total Expenses (Quarterly) | 18.74M |
| Enterprise Value | -1.343M |
| Earnings Yield | -344.2% |
| Normalized Earnings Yield | -349.38 |